GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA

  • Unique Paper ID: 211253
  • Volume: 13
  • Issue: 6
  • PageNo: 4025-4031
  • Abstract:
  • Oral squamous cell carcinoma (OSCC) is the predominant histological subtype of oral cancer and remains a significant global health challenge. Conventional treatments, including surgery, radiotherapy, and chemotherapy, can cause substantial morbidity, while tumour recurrence, metastasis, and therapeutic resistance continue to affect clinical outcomes. RNA interference (RNAi) is an emerging molecular approach that enables sequence-specific regulation of gene expression and offers opportunities for targeted cancer therapy. This review examines the molecular mechanisms of RNA interference and evaluates its potential applications in OSCC, with particular emphasis on small interfering RNA (siRNA), microRNA (miRNA), oncogenic signaling pathways, targeted delivery systems, and translational limitations. RNAi-mediated gene regulation offers a potential strategy for suppressing oncogenic pathways associated with tumour proliferation, apoptosis resistance, invasion, metastasis, and treatment resistance. siRNA can selectively degrade complementary messenger RNA, whereas miRNA mimics and inhibitors can modify broader post-transcriptional regulatory networks. Lipid nanoparticles, polymeric nanocarriers, liposomes, and extracellular vesicles are being investigated to improve RNA stability and intracellular delivery. Nevertheless, inefficient tumour targeting, endosomal entrapment, off-target effects, immune activation, and limited OSCC-specific clinical validation remain major challenges. RNA interference represents a promising research direction for precision oncology in OSCC. Future progress will depend on validated molecular targets, effective delivery systems, comprehensive safety assessment, and rigorous clinical evaluation. At present, RNAi-based approaches should be regarded as investigational strategies rather than established treatments for OSCC.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{211253,
        author = {Periasamy Asokan Jayasri and Bharath Praveen Kumar Sivasundar and Dhinesh Kumar and Bhavadharani Manickavasagam and Bhuvana Devi Navaneetha Gopal and Danishtha Mohanraj and Dhivya Velusamy and Ezhilarasan Murugesan},
        title = {GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {6},
        pages = {4025-4031},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=211253},
        abstract = {Oral squamous cell carcinoma (OSCC) is the predominant histological subtype of oral cancer and remains a significant global health challenge. Conventional treatments, including surgery, radiotherapy, and chemotherapy, can cause substantial morbidity, while tumour recurrence, metastasis, and therapeutic resistance continue to affect clinical outcomes. RNA interference (RNAi) is an emerging molecular approach that enables sequence-specific regulation of gene expression and offers opportunities for targeted cancer therapy. This review examines the molecular mechanisms of RNA interference and evaluates its potential applications in OSCC, with particular emphasis on small interfering RNA (siRNA), microRNA (miRNA), oncogenic signaling pathways, targeted delivery systems, and translational limitations. RNAi-mediated gene regulation offers a potential strategy for suppressing oncogenic pathways associated with tumour proliferation, apoptosis resistance, invasion, metastasis, and treatment resistance. siRNA can selectively degrade complementary messenger RNA, whereas miRNA mimics and inhibitors can modify broader post-transcriptional regulatory networks. Lipid nanoparticles, polymeric nanocarriers, liposomes, and extracellular vesicles are being investigated to improve RNA stability and intracellular delivery. Nevertheless, inefficient tumour targeting, endosomal entrapment, off-target effects, immune activation, and limited OSCC-specific clinical validation remain major challenges. RNA interference represents a promising research direction for precision oncology in OSCC. Future progress will depend on validated molecular targets, effective delivery systems, comprehensive safety assessment, and rigorous clinical evaluation. At present, RNAi-based approaches should be regarded as investigational strategies rather than established treatments for OSCC.},
        keywords = {Oral squamous cell carcinoma; RNA interference; gene silencing; small interfering RNA; microRNA; oncogenes; tumour suppressor genes; nanocarriers; targeted therapy; precision medicine.},
        month = {November},
        }

Cite This Article

Jayasri, P. A., & Sivasundar, B. P. K., & Kumar, D., & Manickavasagam, B., & Gopal, B. D. N., & Mohanraj, D., & Velusamy, D., & Murugesan, E. (2026). GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA. International Journal of Innovative Research in Technology (IJIRT). https://doi.org/doi.org/10.64643/IJIRT211253

Related Articles